A Look At Genworth Financial’s Valuation As Shares Show Mixed Recent Returns

Genworth Financial (GNW) is back on investors’ radar after recent share price swings, with the stock closing at US$8.84. The move has prompted fresh interest in how its long-term returns compare.

See our latest analysis for Genworth Financial.

The recent 1-day share price decline of 2.10% and 7-day share price drop of 5.05% come after a relatively steady 90-day share price gain of 2.20%. The 1-year total shareholder return of 28.49% points to stronger longer term momentum than the short term swings suggest.

If Genworth’s moves have you thinking about where else value or momentum might be building, this is a good moment to broaden your search to 20 top founder-led companies

With Genworth trading at US$8.84 and a consensus price target of US$11.00, the stock sits at a material discount. But is that signaling an undervalued opportunity, or is the market already pricing in its future growth?

Price-to-Earnings of 16x: Is it justified?

Genworth is trading on a P/E of 16x, which looks expensive compared to several benchmarks even with the last close at $8.84 and a price target of $11.00.

The P/E ratio compares the share price to earnings per share and is a quick way to see how much investors are paying for each dollar of current earnings. For an insurance group with established operations across mortgage and long term care, this multiple offers a straightforward read on how the market is valuing its profit stream today.

Here, Genworth’s 16x P/E is below the broader US market average of 18.8x. However, it sits above the peer average of 10x, the US insurance industry average of 11.2x, and an estimated fair P/E of 6.7x. That combination suggests investors are paying a premium to both peers and the fair ratio level the market could move towards, even as earnings have declined over the past 5 years and are forecast to decline on average over the next 3 years.

Explore the SWS fair ratio for Genworth Financial

Result: Price-to-Earnings of 16x (OVERVALUED)

However, earnings pressure over recent years and forecasts pointing to further declines, along with long term care obligations, could both challenge the premium P/E investors are currently paying.

Find out about the key risks to this Genworth Financial narrative.

Another view using cash flows

While the 16x P/E suggests Genworth is trading at a premium to peers, the SWS DCF model points in the opposite direction. On this view, the stock at $8.84 is trading well above an estimated future cash flow value of $0.99. This frames the shares as overvalued. For investors, that gap raises a simple question: which lens feels more reliable for your own decision making?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Genworth Financial for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 46 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mix of potential risks and rewards around Genworth can feel finely balanced. It makes sense to move quickly, review the numbers yourself, and weigh both sides with the help of 1 key reward and 2 important warning signs

Ready to hunt for your next opportunity?

If Genworth has sharpened your focus, do not stop here. Your next idea could be sitting in plain sight if you are willing to look for it.

• Target steady income by scanning companies with resilient payouts using the 9 dividend fortresses.
• Zero in on quality at a reasonable price by filtering for companies that appear mispriced on fundamentals with the 46 high quality undervalued stocks.
• Reduce potential shocks by focusing on companies that show stronger financial resilience through the 64 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com